Patent holdings for IPC class A61K 31/683

Total number of patents in this class: 535

10-year publication summary

54
63
56
58
58
43
24
35
16
14
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Gilead Sciences, Inc.
2222
31
Achillion Pharmaceuticals, Inc.
157
24
N.V. Nutricia
1091
22
SignPath Pharma Inc.
69
15
Aker Biomarine Human Ingredients AS
109
15
Société des Produits Nestlé S.A.
10108
10
National Jewish Health
174
7
Viking Therapeutics, Inc.
62
7
Nutritional Therapeutics, Inc.
15
6
Tasly Pharmaceutical Group Co., Ltd.
121
6
Kao Corporation
5076
5
Acasti Pharma Inc.
8
5
Nippon Suisan Kaisha, Ltd.
190
5
SRX Cardio, LLC
20
5
Janssen Sciences Ireland Unlimited Company
375
5
Merck Sharp & Dohme LLC
3734
5
Arctic Bioscience AS
8
5
Tecton Bg, Inc.
8
5
Johnson & Johnson Vision Care, Inc.
1157
4
Attillaps Holdings
14
4
Other owners 344